New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
16:18 EDTACT, HITK, AKRXActavis to purchase four marketed products from Akorn and Hi-Tech Pharmacal
Actavis (ACT) announced that it has entered into agreements with Akorn (Akrx) and Hi-Tech Pharmacal (HITK) to purchase four currently marketed products and one product under development for cash consideration. The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech. Financial terms of the agreements were not disclosed. The agreements include three products marketed under Abbreviated New Drug Applications and one product marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream. The agreements also include one product under development.
News For ACT;AKRX;HITK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2015
10:01 EDTAKRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:54 EDTAKRXAkorn initiated with a Neutral at Susquehanna
Subscribe for More Information
July 17, 2015
07:25 EDTAKRXAkorn risk/reward favorable into restatements, says JPMorgan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use